Industry: Pharmaceuticals, Biotechnology
Insert Therapeutics is focused on designing, developing and commercializing delivery-enhanced therapeutics using our patented class of polymeric delivery systems, which we have called our ” CyclosertÔ ” family of linear cyclodextrin-containing polymers. We are developing proprietary CyclosertÔ -drug conjugates using off-patent compounds that have documented efficacy, but which also have known issues relating to their solubility, stability, undesirable side effects or poor pharmacokinetics that we can improve significantly with CyclosertÔ . Insert was founded in February 2000 and is headquartered in Pasadena, California. Insert is a majority-owned subsidiary of Arrowhead Research Corporation. ( www.insertt.com )
Insert Therapeutics , Inc.
129 N. Hill Ave. Suite 104
Pasadena, California 91106
USA
Tel: (626) 683-7200
Fax: (626) 683-7220